Please provide your email address to receive an email when new articles are posted on . Gonadotropin-releasing hormone analogue use was not associated with increased use of subsequent gender-affirming ...
New evidence shows GnRH antagonist stimulation outperforms PPOS for oocyte yield in young high-risk IVF patients, supporting ...
Please provide your email address to receive an email when new articles are posted on . “Puberty blockers play an important role in postponing puberty in adolescents with gender identity issues,” ...
Ovarian function suppression (OFS) with gonadotropin-releasing hormone agonists (GnRHas) is a standard of care for premenopausal patients with high-risk stage II/III hormone receptor–positive breast ...
In one of the largest analyses conducted so far on ovarian stimulation strategies, researchers have reported that the gonadotropin-releasing hormone (GnRH) antagonist protocol results in significantly ...
Phase II trial of weekly docetaxel (D) and complete androgen blockade (CAB) prior to radical prostatectomy (RP) in high-risk localized prostate cancer (PC) patients (pts) % Patients with T ≤ 0.5 ng/mL ...
Whether you get your news from Fox, CNN, or TikTok, there's a chance you've noticed that puberty blockers have been the subject of semi-recent conservative legislation. That legislation, to be clear, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback